• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Glucagon-like peptide-1 receptor agonists and the appropriate measurement of gastric emptying.

作者信息

Horowitz Michael, Rayner Christopher K, Marathe Chinmay S, Wu Tongzhi, Jones Karen L

机构信息

Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, Australia.

Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia.

出版信息

Diabetes Obes Metab. 2020 Dec;22(12):2504-2506. doi: 10.1111/dom.14166. Epub 2020 Sep 3.

DOI:10.1111/dom.14166
PMID:32749029
Abstract
摘要

相似文献

1
Glucagon-like peptide-1 receptor agonists and the appropriate measurement of gastric emptying.胰高血糖素样肽-1受体激动剂与胃排空的恰当测量
Diabetes Obes Metab. 2020 Dec;22(12):2504-2506. doi: 10.1111/dom.14166. Epub 2020 Sep 3.
2
Glucagon-like peptide-1 receptor agonists, weight loss, and gastric emptying: have I gut news for you.胰高血糖素样肽-1受体激动剂、体重减轻与胃排空：我有重要消息要告诉你。
Obesity (Silver Spring). 2022 Aug;30(8):1533-1534. doi: 10.1002/oby.23525.
3
Accurate Measurements of Gastric Emptying and Gastrointestinal Symptoms in the Evaluation of Glucagon-like Peptide-1 Receptor Agonists.在胰高血糖素样肽-1受体激动剂评估中对胃排空和胃肠道症状的准确测量。
Ann Intern Med. 2023 Nov;176(11):1542-1543. doi: 10.7326/M23-2019. Epub 2023 Nov 7.
4
Trust the Gold Standard: All Glucagon-like Peptide-1 Receptor Agonists Can Delay Gastric Emptying.信赖金标准：所有胰高血糖素样肽-1受体激动剂均可延缓胃排空。
Anesthesiology. 2024 Jan 1;140(1):178-180. doi: 10.1097/ALN.0000000000004752.
5
Regulation of islet hormone release and gastric emptying by endogenous glucagon-like peptide 1 after glucose ingestion.葡萄糖摄入后内源性胰高血糖素样肽-1对胰岛激素释放和胃排空的调节作用。
J Clin Endocrinol Metab. 2008 Dec;93(12):4909-16. doi: 10.1210/jc.2008-0605. Epub 2008 Sep 30.
6
Delayed Gastric Emptying with Perioperative Use of Glucagon-like Peptide-1 Receptor Agonists.胰高血糖素样肽-1受体激动剂围手术期使用与胃排空延迟
Am J Med. 2023 Dec;136(12):e233-e234. doi: 10.1016/j.amjmed.2023.07.016. Epub 2023 Aug 9.
7
Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects.红霉素可拮抗胰高血糖素样肽1引起的胃排空减速，并在健康受试者中揭示其促胰岛素分泌作用。
Diabetes. 2005 Jul;54(7):2212-8. doi: 10.2337/diabetes.54.7.2212.
8
Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients.液体试验餐后的胃排空、葡萄糖反应及胰岛素分泌：外源性胰高血糖素样肽-1（GLP-1）-（7-36）酰胺对2型（非胰岛素依赖型）糖尿病患者的影响
J Clin Endocrinol Metab. 1996 Jan;81(1):327-32. doi: 10.1210/jcem.81.1.8550773.
9
Comparative effects of prolonged and intermittent stimulation of the glucagon-like peptide 1 receptor on gastric emptying and glycemia.胰高血糖素样肽 1 受体延长和间断刺激对胃排空和血糖的比较影响。
Diabetes. 2014 Feb;63(2):785-90. doi: 10.2337/db13-0893. Epub 2013 Oct 2.
10
Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans.在健康人体中，胰高血糖素样肽1对胃排空的抑制作用超过其促胰岛素分泌作用。
Am J Physiol. 1997 Nov;273(5):E981-8. doi: 10.1152/ajpendo.1997.273.5.E981.

引用本文的文献

1
A narrative review of glucagon-like peptide-1 receptor agonists prior to deep sedation or general anesthesia.在深度镇静或全身麻醉前使用胰高血糖素样肽-1受体激动剂的叙述性综述。
J Anesth Analg Crit Care. 2025 Mar 28;5(1):16. doi: 10.1186/s44158-025-00237-y.
2
Physiology and Pharmacology of Effects of GLP-1-based Therapies on Gastric, Biliary and Intestinal Motility.基于胰高血糖素样肽-1的疗法对胃、胆道和肠道运动影响的生理学与药理学
Endocrinology. 2024 Nov 26;166(1). doi: 10.1210/endocr/bqae155.
3
Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide.
胰高血糖素样肽-1受体激动剂和替尔泊肽导致胃排空延迟的临床后果
J Clin Endocrinol Metab. 2024 Dec 18;110(1):1-15. doi: 10.1210/clinem/dgae719.
4
GLP-1 Receptor Agonists Models for Type 1 Diabetes: A Narrative Review.1型糖尿病的胰高血糖素样肽-1受体激动剂模型：叙述性综述
J Diabetes Sci Technol. 2025 Mar;19(2):332-339. doi: 10.1177/19322968241285925. Epub 2024 Oct 16.
5
Incretin-based therapies for the management of cardiometabolic disease in the clinic: Past, present, and future.基于肠促胰岛素的疗法在临床中治疗心脏代谢疾病的应用：过去、现在与未来。
Med Res Rev. 2025 Jan;45(1):29-65. doi: 10.1002/med.22070. Epub 2024 Aug 14.
6
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review.胰高血糖素样肽 1 受体激动剂与口服药物的药物相互作用：系统评价。
Drug Saf. 2024 May;47(5):439-451. doi: 10.1007/s40264-023-01392-3. Epub 2024 Jan 25.
7
Normal and disordered gastric emptying in diabetes: recent insights into (patho)physiology, management and impact on glycaemic control.糖尿病患者的正常和异常胃排空：（病理）生理学、管理和对血糖控制影响的最新见解。
Diabetologia. 2022 Dec;65(12):1981-1993. doi: 10.1007/s00125-022-05796-1. Epub 2022 Oct 4.
8
Effects of efpeglenatide versus liraglutide on gastric emptying, glucose metabolism and beta-cell function in people with type 2 diabetes: an exploratory, randomized phase Ib study.在 2 型糖尿病患者中，比较 efpeglenatide 与利拉鲁肽对胃排空、糖代谢和胰岛β细胞功能的影响：一项探索性、随机的 Ib 期研究。
BMJ Open Diabetes Res Care. 2021 Jun;9(1). doi: 10.1136/bmjdrc-2021-002208.
9
Gastric Sensory and Motor Functions and Energy Intake in Health and Obesity-Therapeutic Implications.胃感觉和运动功能以及健康和肥胖中的能量摄入——治疗意义。
Nutrients. 2021 Apr 1;13(4):1158. doi: 10.3390/nu13041158.
10
Gut-Based Strategies to Reduce Postprandial Glycaemia in Type 2 Diabetes.基于肠道的策略来降低 2 型糖尿病的餐后血糖
Front Endocrinol (Lausanne). 2021 Apr 9;12:661877. doi: 10.3389/fendo.2021.661877. eCollection 2021.